Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-14FDA Approved: LUTRATE DEPOT — Supplemental Application (Avyxa Pharma, LLC)
FDA approved a supplemental application for LUTRATE DEPOT (leuprolide acetate) from Avyxa Pharma, LLC. This action updates the product’s lab…
-
FDA approval · 2024-11-13FDA Approved: OGIVRI — Supplemental Application (Biocon Biologics Inc.)
The FDA approved a supplemental application for OGIVRI (trastuzumab-dkst) from Biocon Biologics Inc.
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations [Phase 2]
Phase 2 basket trial evaluating tucatinib in combination with trastuzumab across HER2-altered solid tumors, with results posted for several …
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye [NA]
A clinical trial evaluating an integrated imaging system with indocyanine dye for visualizing free flap perfusion in breast reconstruction h…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public [NA]
A terminated clinical trial in Malaysia evaluated a mobile health behavioural intervention to increase breast cancer screening rates among t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial assessing TIL Gean Therapy in combination with immunotherapy for advanced or metastatic refractory breast cancer is curren…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
This clinical trial update describes the 4D PICTURE Project evaluating Metro Mapping to support shared decision making in oncology, sponsore…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: GISEL:Registry of Breast Cancer Patients Treated With ECT
The GISEL registry tracking breast cancer patients treated with electrochemotherapy has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status [Phase 2]
A Phase II neoadjuvant trial in T1c operable, HER2-positive breast cancer defined by TOP2A status has completed.
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person [NA]
The SOAR study is a clinical trial evaluating geriatric assessment and exercise for older adults and their support persons across multiple c…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema [NA]
This clinical trial study evaluates lymphovenous anastomosis to prevent lymphedema in breast cancer patients, and the trial is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer [Phase 1]
This is a Phase 1 trial evaluating ipatasertib plus palbociclib and fulvestrant versus placebo plus palbociclib and fulvestrant in hormone r…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Onset of Sensory Block After Thoracic ESP Block
This clinical trial update notes the onset of sensory block after thoracic erector spinae plane (ESP) block in patients undergoing breast ca…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO [Phase 2]
Phase 2 trial comparing a CDK4/6 inhibitor with endocrine therapy to chemotherapy with endocrine therapy in advanced/metastatic breast cance…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: APBI Proton Feasibility and Phase II Study [Phase 1, Phase 2]
A trial evaluating proton therapy for accelerated partial breast irradiation in early-stage breast cancer (Stage IA-IIA) completed Phase 1 a…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating preoperative partial breast irradiation for early-stage breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update on eribulin in combination with anlotinib for HER2-negative locally advanced or metastatic breast cancer; curr…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Survey Study: Financial Impact of Breast Cancer Treatment
A completed survey study evaluating the financial impact of breast cancer treatment on patients.
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer [Phase 1]
Phase 1 trial update of palbociclib, letrozole, and venetoclax in ER and BCL-2 positive breast cancer; trial status is ACTIVE_NOT_RECRUITING…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Persistent Organic Pollutants and Breast Cancers (POPCASE) [NA]
The POPCASE trial is listed as active-not-recruiting and is evaluating the relationship between persistent organic pollutants and breast can…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: "The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients" [Phase 2]
A Phase 2 clinical trial is evaluating memantine to prevent or lessen paclitaxel-induced toxicity in breast cancer patients and is currently…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients
The In4M study, a trial evaluating four methods to assess physical function in cancer patients, has completed, including participants with b…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery [NA]
A clinical trial evaluating nicotine replacement therapy, motivational interviewing, cognitive behavioral therapy, and hypnotherapy for smok…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Observational study of patients treated with trastuzumab deruxtecan (Enhertu) for HER2-positive and HER2-low unresectable/metastatic breast …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Evaluating Illustrated Vs. Traditional Pamphlets for Enhancing Self-Care in Radiation Therapy Patients [NA]
A completed clinical trial comparing illustrated versus traditional pamphlets to enhance self-care in radiation therapy patients, including …